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Abstract A short and efficient synthesis of resormycin, a metabolite of
Streptomyces platensis MJ953-SF5 with herbicidal and antifungal activity,
is described. The key step in our synthetic approach is a late-stage ste-
reospecific dehydration of a β-hydroxy amino acid to install the Z-olefin.
Because of the modular nature of the synthesis, access to analogues for
biological evaluation is readily available.
Key words Streptomyces, antifungal agents, tripeptides, natural prod-
ucts, amino acids, total synthesis
Natural products have been and still are a large reser-
voir of new biologically active substances, and to this very
day, numerous drugs and agrochemicals have been devel-
oped from naturally occurring lead compounds.1
In 1997, Takeuchi et al. isolated the novel metabolite re-
sormycin2 (1) from Streptomyces platensis MJ953-SF5, a
strain collected from the soil at Yokohama, Japan (Figure 1).
The molecule showed remarkable growth inhibition of
monocotyledonous and dicotyledonous weeds. Moreover,
the compound inhibited the growth of phytopathogenic
fungi, in particular Cercospora beticola, Pyricularia oryzae,
Botrytis cinerea, and Ustilago maydis with a minimal inhibi-
tory concentration (MIC) lower than 10 μg/mL.2
Resormycin is composed of three rare unnatural amino
acid residues, β-homolysine, 3-hydroxy-L-valine, and an
unusual chlorinated resorcyl-2,3-dehydropropenoic amino
acid at the C terminus. The resorcyl fragment is attached to
the dipeptide unit via a Z-alkene.2 In 2015, Momose et al.
isolated two novel peptide metabolites from Streptomyces
sp. MK932-CF8, androprostamine A (2) and B (3),3 both
sharing the tripeptide backbone core with resormycin (Fig-
ure 1). The compounds inhibit androgen-dependent growth
of human prostate cancer cells and repress the androgen-
induced expression of androgen-receptor-regulated genes.3
Figure 1  Structures of resormycin (1), androprostamine A (2), and an-
droprostamine B (3)
Our continuous interest in natural compounds endowed
with biological activity, together with the distinctive struc-
tural architecture of resormycin, prompted us to develop a
synthesis of 1, which may, in principle, have value in the
preparation of 2 and 3 as well as other analogues. The
strong interest in these molecules is confirmed by the re-
cent synthesis of resormycin (1) and androprostamine A (2)
by Shibasaki et al.4 reported in the literature during the last
part of this work.
The Shibasaki strategy4 is based on the use of Horner–
Wadsworth–Emmons (HWE) olefination as a key reaction
to install the 2,3-dehydroamino acid moiety. The olefination
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in poor yield (26% crude), and requires a troublesome puri-
fication. The synthesis of resormycin is achieved in a 9%
overall yield considering the longest linear sequence of six
steps.
Our retrosynthetic plan is depicted in Scheme 1. We en-
visioned that the Z-olefin could be obtained by stereospe-
cific dehydration of N-acyl-β-hydroxy α-amino acid 4.5 The
aldol condensation of N-(diphenylmethylene)glycine tert-
butyl ester with the appropriately protected aldehyde 7 was
expected to furnish amino alcohol 5, whereas its counter-
part, the acid 6, could be obtained by coupling 3-hydroxy-
L-valine 8 and suitably protected β-homolysine 9.
Scheme 1  Retrosynthetic approach to resormycin (1)
Di-Alloc-β-homolysine 11 (Alloc = allyloxycarbonyl) was
obtained in 73% yield by treatment of β-homolysine 10
with allyl chloroformate and K2CO3 in water6 (Scheme 2);
reaction of 11 with N-hydroxysuccinimide and EDC·HCl
in DMF, followed by coupling of the NHS ester with
3-hydroxy-L-valine produced acid 12 in 86% yield over two
steps.
Scheme 2  Synthesis of dipeptide 12. Reagents and conditions: (a) allyl 
chloroformate, K2CO3, H2O, 0 °C to r.t., 16 h, 73%; (b) NHS, EDC·HCl, 
DMF, r.t., 16 h; (c) 3-hydroxy-L-valine, Et3N, dioxane–H2O (2:1), r.t., 2 h, 
86% (over 2 steps).
The synthesis of the aryl core is depicted in Scheme 3.
We envisioned that the shortest and easiest approach for
the synthesis of aldehyde 15 could be the chlorination of
commercially available 3,5-dihydroxybenzaldehyde at the
C-4 position. Initially, several attempts using NCS/PTSA/NaCl,7
NaOCl/KOH,8 NCS/AcOH,9 and NCS/MeOH10 were tried to
obtain 4-chloro-3,5-dihydroxybenzaldehyde, but in all the
cases either chlorination occurred exclusively at the C-2 po-
sition or there was no product formation at all. Thus, we
followed a different strategy. Allylation of commercially
available 4-chloro-3,5-dihydroxybenzoic acid (13) by using
K2CO3/DMF11 at room temperature gave ester 14 in 92%
yield (Scheme 3). Treatment of ester 14 with DIBAL-H in
CH2Cl2 at –78 °C12 cleanly furnished the benzyl alcohol,
which was immediately oxidized by using PCC/NaOAc in
CH2Cl2 to give aldehyde 15 in 80% yield over two steps.
Scheme 3  Synthesis of the aryl core. Reagents and conditions: (a) allyl 
bromide, K2CO3, DMF, 0 °C to r.t., 2 h, 92%; (b) DIBAL-H, CH2Cl2, –78 °C, 
1 h; (c) PCC, NaOAc, 10 °C to r.t., 2 h, 80% (over 2 steps); (d) 1. i-Pr2NH, 
n-BuLi, THF, 0 °C, 30 min, then N-(diphenylmethylene)glycine tert-butyl 
ester in THF, –78 °C, 30 min; 2. TMSCl, –78 °C to r.t. over 1 h, then ZnCl2 
(cat.), 15 in THF, r.t., 2 h; 3. 10% citric acid, r.t., 16 h, 81% (from 15).
The aldehyde now had to be converted into the corre-
sponding amino alcohol (±)-16, for the coupling with the
dipeptide counterpart. Kirk et al.13 reported that ZnCl2-
catalyzed aldol condensation of a glycine equivalent with
aromatic aldehydes mainly gave the threo diastereomers.
Thus, following Kirk’s protocol, compound 15 was con-
densed with N-(diphenylmethylene)glycine tert-butyl ester
at –78 °C in the presence of 5 mol% of ZnCl2. The imine and
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l.the silyl ether functionalities were removed by mild hydro-
lysis with 10% citric acid to provide the key intermediate
(±)-16 in 81% yield (threo/erythro, 95:5).
The amide coupling of amino alcohol (±)-16 and acid 12
by using HBTU/DMAP furnished amide 17 in 73% yield as a
mixture of threo isomers (Scheme 4). Stereospecific dehy-
dration of the threo-N-acyl-β-hydroxy-α-amino acid frag-
ment was performed by using Martin’s sulfurane [diphen-
ylbis(1,1,1,3,3,3-hexafluoro-2-phenyl-2-propyl)sulfurane]
under neutral conditions.5 The stereospecific formation of
the Z-dehydroamino acid is compatible with an E2 elimina-
tion process. Since Martin’s sulfurane is known to react
with alcohols to give ROSPh2OC(CF3)2Ph intermediates, the
reaction is likely to proceed through the formation of inter-
mediate 18, followed by trans E2 elimination from the anti-
periplanar conformation.14,15 The dehydration smoothly oc-
curred at room temperature without base to produce Z-
alkene 19 in 60% yield. One-pot deprotection of the allyl
and Alloc groups by using Pd(PPh3)4 as catalyst in combina-
tion with N-methylaniline and dimedone16 as an allyl scav-
enger gave only a partially deprotected compound. Con-
versely, the palladium-catalyzed hydrostannolytic cleavage
of Alloc and allyl groups using SnBu3H and AcOH in CH2Cl2,
followed by careful treatment with TFA in CH2Cl2 at 0°C17
resulted in clean deprotection to give the final product re-
sormycin (1), whose spectroscopic data matched those re-
ported in the literature.4
In conclusion, we have designed and accomplished a
convergent total synthesis of resormycin with the longest
linear sequence of eight steps in 25% overall yield. The key
steps in our synthetic approach include the late-stage ste-
reospecific dehydration of a β-hydroxy amino acid to install
the Z-olefin and palladium-catalyzed one-pot deprotection
of allyl and Alloc groups. This straightforward synthetic ap-
proach constitutes also a formal synthesis of androprost-
amines3,4 and is amenable to generate diverse analogues for
biological investigation.
All reagents and solvents were reagent grade or were purified by
standard methods before use. Melting points were determined in
open capillaries on an SMP3 apparatus and are uncorrected. 1H NMR
spectra were recorded on Varian Mercury 300 MHz and Bruker AV600
spectrometers; TMS was used as an internal standard. 13C NMR spec-
tra were recorded on Varian 300 MHz and Bruker AV600 spectrome-
ters. Optical rotations were measured on a Perkin Elmer 241 polarim-
eter. IR spectra were recorded on a Perkin Elmer 1310 spectropho-
tometer. The elemental analyses were recorded on a CARLO ERBA EA
1108 instrument. HPLC analyses were performed by using a Jasco PU-
980 pump equipped with a Jasco UV-975 (λ = 220 nm) UV–vis detec-
tor and a Phenomenex Lux Amylose-2 column (4.6 mm i.d. × 150 mm,
5 μm) at a flow rate of 1 mL·min−1, using n-hexane–i-PrOH (7:3) as
eluent. Preparative HPLC was performed using a 1525 Extended Flow
Binary HPLC pump, equipped with a Waters 2489 UV–vis detector
and a Phenomenex Lux Amylose-2 column (21.2 mm i.d. × 250 mm)
at a flow rate of 15 mL·min−1 using n-hexane–i-PrOH (1:1) as eluent.
Solvents were routinely distilled prior to use; anhydrous THF and
Et2O were obtained by distillation from sodium benzophenone ketyl;
Scheme 4  Synthesis of resormycin. Reagents and conditions: (a) HBTU, DMAP, DMF, 0 °C, 2 h, then r.t., 1 h, 73%, (b) Martin’s sulfurane, CH2Cl2, 0 °C to 
r.t., 16 h, 60%; (c) SnBu3H, AcOH, [PdCl2(PPh3)2], CH2Cl2, r.t., 12 h; (d) TFA, CH2Cl2, 0 °C to r.t., 2 h, 97% (over 2 steps).
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l.anhydrous CH2Cl2 was obtained by distillation from phosphorus pent-
oxide. All reactions requiring anhydrous conditions were performed
under a positive nitrogen flow and all glassware were oven-dried
and/or flame-dried. Isolation and purification of the compounds were
performed by flash column chromatography on silica gel 60 (230–400
mesh). Analytical TLC was conducted on TLC plates (silica gel 60 F254,
aluminum foil). Compounds on TLC plates were detected under UV
light at 254 and 365 nm or were revealed by spraying with 10% phos-
phomolybdic acid (PMA) in EtOH. 3-Hydroxy-L-valine was purchased
from Acros Organic.L-β-Homolysine dihydrochloride (10) was pur-
chased from abcr, Germany (http://www.abcr.de).
(S)-3,7-Bis(allyloxycarbonylamino)heptanoic Acid (11)
A cold solution of K2CO3 (948 mg, 6.86 mmol) in H2O (2 mL), followed
by allyl chloroformate (0.36 mL, 3.43 mmol), was added dropwise to a
solution of β-homolysine dihydrochloride (10; 320 mg, 1.37 mmol) in
H2O (2 mL) at 0 °C. After complete addition, the reaction mixture was
stirred at r.t. for 16 h; then it was cooled to 0 °C and acidified by using
2 N HCl. The aqueous layer was extracted with EtOAc (2 × 10 mL). The
combined organic extracts were washed with brine (7 mL), dried over
anhydrous Na2SO4, and concentrated in vacuo. Purification by flash
column chromatography (silica gel, MeOH–CH2Cl2, 7–10%) yielded
compound (–)-11.
Yield: 330 mg (73%); colorless solid; mp 77–78 °C; [α]D23 –12.8 (c
1.15, CHCl3); Rf = 0.4 (MeOH–CH2Cl2, 10:90).
IR (film): 3480, 3400, 3100, 3000, 1750, 1720, 1680, 1550, 1440,
1300, 800, 785, 730 cm–1.
1H NMR (300 MHz, CD3OD): δ = 5.99–5.85 (m, 2 H), 5.31 (ddt, J = 17.1,
1.6, 1.5 Hz, 2 H), 5.16 (ddt, J = 10.6, 1.6, 1.5 Hz, 2 H), 4.50 (dt, J = 5.4,
1.5 Hz, 4 H), 4.02–3.84 (m, 1 H), 3.09 (t, J = 6.7 Hz, 2 H), 2.44 (dd, J =
6.9, 2.0 Hz, 2 H), 1.66–1.27 (m, 6 H).
13C NMR (75 MHz, CD3OD): δ = 175.2, 158.8, 158.2, 134.6, 134.5, 117.3
(2 C), 66.2 (2 C), 49.4, 41.5, 40.9, 35.3, 30.6, 24.2.
Anal. Calcd for C15H24N2O6: C, 54.87; H, 7.37; N, 8.53. Found: C, 54.96;
H, 7.36; N, 8.55.
(S)-2-[(S)-3,7-Bis(allyloxycarbonylamino)heptanamido]-3-hy-
droxy-3-methylbutanoic Acid (12)
To a stirred solution of compound (–)-11 (508 mg, 1.55 mmol) in an-
hydrous DMF (5.1 mL, 0.3 M), NHS (409 mg, 3.56 mmol) and EDC·HCl
(682 mg, 3.56 mmol) were sequentially added under a N2 atmo-
sphere. The clear solution obtained was stirred overnight at r.t. The
reaction mixture was poured into ice water (30 mL) and the aqueous
layer was extracted with EtOAc (2 × 10 mL). The combined organic ex-
tracts were washed with cold brine (5 × 5 mL), dried over anhydrous
Na2SO4, and concentrated in vacuo to give the NHS ester (785 mg).
The crude ester was used without further purification. To a solution
of 3-hydroxy-L-valine (269 mg, 2.02 mmol) in dioxane–H2O (1:1, 26.6
mL) was added Et3N (0.64 mL, 4.60 mmol) followed by the dropwise
addition of a solution of the above NHS ester (785 mg, 1.84 mmol) in
dioxane (13.4 mL). The resultant solution was stirred at r.t. for 2 h.
The solvent was removed in vacuo and diluted with aq NaHCO3 (5
mL), and the aqueous layer was washed with EtOAc (2 ×10 mL). The
aqueous layer was cooled to 0 °C and acidified by using 2 N HCl; then
it was extracted with EtOAc (2 × 20 mL), washed with brine (10 mL),
and dried over anhydrous Na2SO4. The solvent was concentrated in
vacuo to yield 12.
Yield: 595 mg (86%); pale yellow solid; mp 63–65 °C; [α]D23 –18.4 (c
1.0, CHCl3); Rf = 0.1 (MeOH–CH2Cl2, 10:90).
IR (film): 3490, 3380, 3105, 3000, 1730, 1670, 1625, 1550, 1445,
1295, 770, 730 cm–1.
1H NMR (300 MHz, CD3OD): δ = 5.99–5.83 (m, 2 H), 5.28 (ddt, J = 17.1,
1.6, 1.5 Hz, 2 H), 5.16 (ddt, J = 10.6, 1.6, 1.5 Hz, 2 H), 4.50 (dt, J = 5.4,
1.5 Hz, 4 H), 4.42 (s, 1 H), 3.95–3.91 (m, 1 H), 3.09 (t, J = 6.4 Hz, 2 H),
2.45 (dd, J = 6.9, 2.6 Hz, 2 H), 1.68–1.29 (m, 6 H), 1.29 (s, 3 H), 1.26 (s,
3 H).
13C NMR (75 MHz, CD3OD): δ = 178.0, 173.3, 158.8, 158.3, 134.6,
134.5, 117.5, 117.4, 73.4, 66.4, 66.2, 62.6, 49.9, 42.8, 41.5, 35.5, 30.6,
27.8, 26.1, 24.1.
Anal. Calcd for C20H33N3O8: C, 54.16; H, 7.50; N, 9.47. Found: C, 54.22;
H, 7.48; N, 9.49.
Allyl 3,5-Bis(allyloxy)-4-chlorobenzoate (14)
A suspension of 4-chloro-3,5-dihydroxybenzoic acid (13; 0.50 g, 2.65
mmol) and anhydrous K2CO3 (2.50 g, 18.55 mmol) in anhydrous DMF
(5 mL, 0.5 M) was stirred for 10 min and cooled to 0 °C. Allyl bromide
(0.80 mL, 9.28 mmol) was added dropwise at 0 °C and the mixture
was stirred for 1 h at r.t. Then the reaction mixture was poured into
ice water (25 mL) and the aqueous layer was extracted with Et2O (2 ×
10 mL); the combined organic extracts were washed with brine (5
mL) and dried over anhydrous Na2SO4. The solvent was removed in
vacuo. Purification by flash column chromatography (silica gel, EtOAc–
PE, 3:97) afforded compound 14.
Yield: 750 mg (92%); colorless oil; Rf = 0.3 (EtOAc–PE, 5:95).
IR (film): 3040, 3100, 3000, 1750, 1625, 1450, 1350, 1295, 1270,
1150, 1130, 1000 cm–1.
1H NMR (300 MHz, CDCl3): δ = 7.29 (s, 2 H), 6.18–5.94 (m, 3 H), 5.53–
5.28 (m, 6 H), 4.82 (dt, J = 5.9, 1.3 Hz, 2 H), 4.67 (dt, J = 5.2, 1.6 Hz, 4
H).
13C NMR (75 MHz, CDCl3): δ = 165.7, 155.2 (2 C), 132.4 (2 C), 132.2,
128.9, 118.7, 118.3 (3 C), 107.3 (2 C), 70.1 (2 C), 66.1.
Anal. Calcd for C16H17ClO4: C, 62.24; H, 5.55. Found: C, 62.33; H, 5.56.
3,5-Bis(allyloxy)-4-chlorobenzaldehyde (15)
A 1 M solution of DIBAL-H in CH2Cl2 (4.30 mL, 4.30 mmol) was added
dropwise to a stirred solution of 14 (532 mg, 1.72 mmol) in CH2Cl2
(11.4 mL, 0.15 M) at –78 °C under a N2 atmosphere. After complete
addition, the reaction mixture was stirred at –78 °C for 1 h. A solution
of saturated aq Rochelle salt (1 mL) was added followed by 2 N HCl (5
mL). The reaction mixture was stirred vigorously until the two layers
became clear. The organic layer was separated and the aqueous layer
was extracted with CH2Cl2 (10 mL); the combined organic extracts
were washed with brine (6 mL), dried over anhydrous Na2SO4, and
concentrated in vacuo to afford the benzyl alcohol (418 mg) as a col-
orless oil. The alcohol was used for the next step without further pu-
rification.
To a stirred suspension of PCC (709 mg, 3.29 mmol) and NaOAc (67
mg, 0.82 mmol) in anhydrous CH2Cl2 (3 mL) cooled to 10 °C, the above
benzyl alcohol (418 mg, 1.64 mmol) in CH2Cl2 (5 mL) was added drop-
wise. The reaction mixture was stirred for 2 h at r.t. In vacuo concen-
tration followed by flash column chromatography (silica gel) fur-
nished 15.
Yield: 346 mg (80%, over 2 steps); white solid; mp 88–89 °C; Rf = 0.2
(EtOAc–PE, 5:95).
IR (film): 3080, 2965, 2920, 1720, 1615, 1460, 1280, 1120, 760 cm–1.© Georg Thieme Verlag  Stuttgart · New York — Synthesis 2017, 49, 5351–5356
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l.1H NMR (300 MHz, CDCl3): δ = 9.88 (s, 1 H), 7.09 (s, 2 H), 6.15–5.99
(m, 2 H), 5.49 (ddt, J = 17.0, 1.6, 1.5 Hz, 2 H), 5.33 (ddt, J = 10.1, 1.6, 1.5
Hz, 2 H),4.68 (dt, J = 5.0, 1.5 Hz, 4 H).
13C NMR (75 MHz, CDCl3): δ = 190.0, 155.9 (2 C), 135.0, 132.0 (2 C),
118.4 (3 C), 106.8 (2 C), 70.0 (2 C).
Anal. Calcd for C13H13ClO3: C, 61.79; H, 5.19. Found: C, 61.70; H, 5.18.
tert-Butyl 2-Amino-3-[3,5-bis(allyloxy)-4-chlorophenyl]-3-
hydroxypropanoate (16)
A 1.6 M solution of n-BuLi in hexane (1.3 mL, 1.37 mmol) was added
dropwise to a stirred solution of i-Pr2NH (0.20 mL, 1.43 mmol) in an-
hydrous THF (4 mL) at 0 °C under a N2 atmosphere. The pale yellow
solution obtained was stirred at 0 °C for 30 min. The thus generated
LDA solution was added dropwise to a solution of N-(diphenylmethy-
lene)glycine tert-butyl ester (0.37 g, 1.25 mmol) in THF (4 mL) cooled
to –78 °C under a N2 atmosphere. The wine red solution obtained was
stirred at –78 °C for 30 minutes. TMSCl (0.47 mL, 3.75 mmol) was
added dropwise (color changes from wine red to pale yellow); after
complete addition, the reaction mixture was warmed to r.t. over 1 h.
The yellow solution obtained was added dropwise to a stirred solu-
tion of 15 (0.316 g, 1.25 mmol) and ZnCl2 (0.16 mL, 0.16 mmol) in an-
hydrous THF (4 mL) at r.t., and stirred for 2 h. The reaction mixture
was cooled to 0 °C and quenched by dropwise addition of 10% citric
acid (6 mL). After complete addition, the reaction mixture was stirred
overnight at r.t. THF was removed in vacuo and the aqueous layer was
cooled to 0 °C and basified by using saturated aq NaHCO3 and extract-
ed with EtOAc (2 × 25 mL). The combined organic extracts were
washed with brine (15 mL) and dried over anhydrous Na2SO4; the sol-
vent was then removed in vacuo. The crude was purified by flash col-
umn chromatography (silica gel, MeOH–CH2Cl2, 0.5:99.5) to give 16.
Yield: 0.393 g (81%); colorless oil; Rf = 0.25 (MeOH–CH2Cl2, 2:98).
IR (film): 3440, 3360, 3100, 3020, 2985, 2930, 1750, 1615, 1480,
1445,1400, 1290, 1180, 1155, 1120, 950, 880, 765 cm–1.
1H NMR (300 MHz, CDCl3): δ (major stereoisomers in threo/erythro
mixture, 95:5) = 6.61 (s, 2 H), 6.15–5.98 (m, 2 H), 5.46 (ddt, J = 17.5,
1.6, 1.5 Hz, 2 H), 5.30 (ddt, J = 10.4, 1.6, 1.5 Hz, 2 H), 4.72 (d, J = 4.9 Hz,
1 H), 4.61 (dt, J = 5.0, 1.5 Hz, 4 H), 3.49 (d, J = 4.9 Hz, 1 H), 1.40 (s, 9 H).
13C NMR (75 MHz, CDCl3): δ (major stereoisomer) = 172.2, 155.4 (2 C),
140.8, 132.7 (2 C), 117.8 (3 C), 104.7 (2 C), 82.1, 74.2, 70.0 (2 C), 60.9,
28.0 (3 C).
Anal. Calcd for C19H26ClNO5: C, 59.45; H, 6.83; N, 3.65. Found: C,
59.51; H, 6.84; N, 3.65.
tert-Butyl (5S,9S)-9-(Allyloxycarbonylamino)-2-{[3,5-bis(allyloxy)-
4-chlorophenyl](hydroxy)methyl}-5-(2-hydroxypropan-2-yl)-
4,7,15-trioxo-16-oxa-3,6,14-triazanonadec-18-enoate (17)
A stirred solution of acid 12 (201 mg, 0.45 mmol) and amino alcohol
16 (190 mg, 0.50 mmol) in anhydrous DMF (4.5 mL, 0.1 M) was
cooled to 0 °C. HBTU (188.8 mg, 1.58 mmol) and DMAP (60.8 mg,
0.498 mmol) were sequentially added at 0 °C under a N2 atmosphere.
The reaction mixture was stirred at 0 °C for 2 h and then for 1 h at r.t.
The reaction mixture was poured into cold water (30 mL) and the
aqueous layer was extracted with EtOAc (2 × 15 mL). The combined
organic extracts were washed with brine (10 mL), dried over anhy-
drous Na2SO4, and concentrated in vacuo. The residue was purified by
column chromatography (silica gel, MeOH–CH2Cl2, 1.5 to 2.5%) to af-
ford amide 17.
Yield: 270 mg (73%, mixture of diastereomers); Rf = 0.25 (MeOH–CH2Cl2,
3:97).
1H NMR (300 MHz, CD3OD): δ = 6.80–6.70 (m, 2 H) 6.17–6.00 (m, 2
H), 5.98–5.83 (m, 2 H), 5.55–5.47 (m,, 2 H), 5.34–5.11 (m, 6 H), 4.74–
4.37 (m, 10 H), 3.98–3.80 (m, 1 H), 3.15–3.05 (m, 2 H), 2.47–2.30 (m, 2
H), 1.60–1.39 (m, 15 H).
13C NMR (75 MHz, CD3OD): major δ = 173.2, 172.5, 172.2, 170.6,
170.4, 156.3 (2 C), 142.4, 134.4 (4 C), 117.6 (4 C), 117.4, 105.3 (2 C),
83.2, 73.6, 72.9, 70.7 (3 C), 66.2, 61.2, 60.4, 50.0, 42.4, 41.5, 35.2, 30.5,
28.3 (5 C), 24.1.
Anal. Calcd for C39H57ClN4O12: C, 57.88; H, 7.10, N, 6.92. Found: C,
57.79; H, 7.08; N, 6.90.
tert-Butyl (5S,9S)-9-(Allyloxycarbonylamino)-2-[(Z)-3,5-bis(ally-
loxy)-4-chlorobenzylidene]-5-(2-hydroxypropan-2-yl)-4,7,15-tri-
oxo-16-oxa-3,6,14-triazanonadec-18-enoate (19)
A solution of Martin’s sulfurane (49.8 mg, 0.07 mmol) in anhydrous
CH2Cl2 (0.4 mL) was added dropwise to a stirred solution of alcohol 17
(30 mg, 0.04 mmol) in anhydrous CH2Cl2 (0.6 mL) at 0 °C under a N2
atmosphere. The reaction mixture was stirred at r.t. for 3 h. More
Martin’s sulfurane (0.074 mmol) was added and the reaction mixture
was stirred at r.t. for 12 h. The reaction mixture was concentrated in
vacuo and the crude material was purified by flash column chroma-
tography (silica gel, MeOH–CH2Cl2, 1.5%). At this stage, the product
was purified by semi-preparative HPLC (Phenomenex Lux Amylose-2
column, 21.2 mm i.d. × 250 mm; flow rate 15 mL·min−1; n-hexane–
i-PrOH, 1:1; tr = 4.6 min; λ = 220 nm) to furnish pure compound 19.
Yield: 17.5 mg (60%); white solid; mp 72–73 °C; [α]D23 –3.59 (c 0.004,
CHCl3); Rf = 0.2 (MeOH–CH2Cl2, 2:98).
IR (film): 3360, 3045, 2990, 1770, 1755, 1720, 1665, 1610, 1540,
1400, 1300, 1280,1055, 1010, 950, 870 cm–1.
1H NMR (600 MHz, CDCl3): δ = 8.09 (s, 1 H), 7.23 (s, 1 H), 6.71 (s, 2 H),
6.65 (d, J = 8.3 Hz, 1 H), 6.10–6.02 (m, 2 H), 5.94–5.83 (m, 2 H), 5.56
(d, J = 7.5 Hz, 1 H), 5.48 (ddt, J = 17.2, 1.5, 1.6 Hz, 2 H), 5.32–5.24 (m, 4
H), 5.21–5.12 (m, 2 H), 4.87 (br s, 1 H), 4.65–4.46 (m, 8 H), 4.39 (d, J =
8.3 Hz, 1 H), 3.84–3.78 (m, 1 H), 3.76 (s, 1 H), 3.15–3.04 (m, 2 H), 2.50
(dd, J = 14.6, 5.0 Hz, 1 H), 2.46 (dd, J = 14.6, 5.9 Hz, 1 H), 1.53 (s, 9 H),
1.48–1.38 (m, 4 H), 1.33 (s, 3 H), 1.32–1.24 (m, 2 H), 1.21 (s, 3 H).
13C NMR (150 MHz, CDCl3): δ = 171.8, 170.2, 164.2, 156.6, 156.2,
155.4 (2 C), 133.2, 133.0, 132.8 (2 C), 132.7, 132.2, 125.9, 118.0 (2 C),
117.9, 117.7, 113.6, 107.7 (2 C), 83.0, 72.0, 70.1 (3 C), 65.7, 60.2, 49.0,
40.8, 40.4, 33.9, 29.4, 28.2, 28.0, 27.8, 27.6, 25.8, 23.1.
Anal. Calcd for C39H55ClN4O11: C, 59.19; H, 7.01; N, 7.08. Found: C,
59.35; H, 7.03; N 7.06.
Resormycin (1) TFA Salt
SnBu3H (0.04 mL, 0.17 mmol) was added in one portion to a stirred
solution of compound 19 (23 mg, 0.03 mmol), AcOH (0.02 mL, 0.35
mmol), and [PdCl2(PPh3)2] (2 mg, 0.003 mmol) in anhydrous CH2Cl2
(0.8 mL, 0.03 M) under a N2 atmosphere. The reaction mixture was
stirred at r.t. for 2 h and again SnBu3H (0.04 mL, 0.17 mmol) was add-
ed in one portion. The reaction mixture was stirred overnight at r.t.,
then it was concentrated in vacuo to dryness and the solid obtained
was triturated with hexane (2 mL), followed by hexane–MeCN (9:1)
to give crude tert-butyl (Z)-3-(4-chloro-3,5-dihydroxyphenyl)-2-{(S)-
2-[(S)-3,7-diaminoheptanamido]-3-hydroxy-3-methylbutanamido}-
acrylate; Rf = 0.2 (3% NH3 in MeOH–H2O, 1:1).
A solution of the above ester (20 mg) in CH2Cl2 (0.5 mL) was cooled to
0 °C. TFA (0.2 mL) was added dropwise and the reaction mixture was
stirred at r.t. for 2 h. The mixture was concentrated to dryness and the
residue was triturated with Et2O to afford title compound 1.© Georg Thieme Verlag  Stuttgart · New York — Synthesis 2017, 49, 5351–5356
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l.Yield: 13 mg (97%); white solid; mp 123–124 °C; [α]D23 +123.2 (c
0.004, MeOH) {Lit.4 for TFA salt: [α]D23 +127.7 (c 0.44, MeOH)}; Rf = 0.8
(5% NH3 in MeOH–H2O, 1:1).
1H NMR (600 MHz, CD3OD): δ = 7.35 (s, 1 H), 6.83 (s, 2 H), 4.54 (s, 1
H), 3.59–3.52 (m, 1 H); 2.90 (t, J = 7.7 Hz, 2 H), 2.78–2.73 (m, 2 H),
1.75–1.45 (m, 6 H), 1.40 (s, 3 H), 1.38 (s, 3 H).
1H NMR (600 MHz, DMSO-d6) δ = 12.78 (br s, 1 H), 9.80 (br s, 2 H),
9.42 (br s, 1 H), 8.35 (d, J = 8.4 Hz, 1 H), 8.02–7.50 (m, 6 H), 7.00 (s, 1
H), 6.70 (s, 2 H), 5.00–4.90 (m, 1 H), 4.49 (d, J = 8.4 Hz, 1 H), 3.40–3.35
(m, 1 H), 2.72 (t, J = 7.5 Hz, 2 H), 2.70–2.50 (m, 2 H), 1.63–1.25 (m, 6
H), 1.20 (s, 6 H).
13C NMR (150 MHz, DMSO-d6): δ = 169.9, 169.4, 166.1, 158.2 (TFA),
158.0 (TFA), 153.9 (2 C), 132.2, 130.9, 126.7, 121.3 (TFA), 121.2 (TFA),
108.6 (2 C), 108.5, 71.3, 60.4, 48.0, 38.5, 37.1, 31.5, 27.1, 26.5, 26.1,
21.3.
Anal. Calcd for C25H33ClF6N4O11: C, 42.00; H, 4.65; N, 7.84. Found: C,
41.85; H, 4.66; N, 7.86.
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